Gefitinib inhibits the cross-talk between mesenchymal stem cells and prostate cancer cells leading to tumor cell proliferation and inhibition of docetaxel activity
2013 ◽
Vol 114
(5)
◽
pp. 1135-1144
◽
Keyword(s):
2017 ◽
2015 ◽
Keyword(s):
2018 ◽
Vol 75
(24)
◽
pp. 4583-4598
◽
Keyword(s):
Keyword(s):
2017 ◽
Keyword(s):
Keyword(s):
2008 ◽
Vol 29
(3)
◽
pp. 333-340
◽
Keyword(s):